Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
10 December, 2018 03:18 IST
Strides Shasun receives USFDA nod for Cyproheptadine HCl tablets
Source: IRIS | 12 Apr, 2018, 12.00PM
Comments  |  Post Comment

Strides Shasun today announced that its wholly owned subsidiary Strides Pharma Global has received approval for Cyproheptadine Hydrochloride Tablets USP, 4 mg from the United States Food & Drug Administration (US FDA). Cyproheptadine Hydrochloride Tablets is a generic version of Periactin Tablets of Merck & Co. Inc.

According to IQVIA data, the US market for Cyproheptadine Hydrochloride Tablets USP, 4 mg is approximately USD 20 Million. The product will be manufactured at the company's Oral dosage facility at Bangalore and will be marketed by Strides Pharma Inc. in the US Market.

The company has 74 cumulative ANDA filings with USFDA of which 46 ANDAs have been approved as of date and 28 are pending approval.

Shares of the company declined Rs 8.1, or 1.26%, to trade at Rs 633.75. The total volume of shares traded was 15,613 at the BSE (11.47 a.m., Thursday).



Strides Pharma Science Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
HCL Tech to acquire select IBM Software products for USD 1.8 bn - 07-Dec-2018 10:08
Wipro, Alfresco expand pact to offer digital transformation capabilities - 07-Dec-2018 09:59
Indian Hume Pipe Co receives contract worth Rs 2.04 bn - 06-Dec-2018 09:50
Infosys inaugurates technology and innovation hub in Hartford - 06-Dec-2018 09:46
USFDA completes inspection of Lupin's Mandideep location - 05-Dec-2018 15:31
NTPC wins 85MW solar projects in UPNEDA's solar tender - 05-Dec-2018 15:03
Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets - 05-Dec-2018 13:05
Kridhan Infra's associate Co bags orders worth Rs 1.05 bn - 05-Dec-2018 10:06
Lupin launches generic Silodosin capsules in United States - 05-Dec-2018 09:54
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer